JPS628431B2 - - Google Patents

Info

Publication number
JPS628431B2
JPS628431B2 JP3612582A JP3612582A JPS628431B2 JP S628431 B2 JPS628431 B2 JP S628431B2 JP 3612582 A JP3612582 A JP 3612582A JP 3612582 A JP3612582 A JP 3612582A JP S628431 B2 JPS628431 B2 JP S628431B2
Authority
JP
Japan
Prior art keywords
group
compound
carbon atoms
general formula
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3612582A
Other languages
Japanese (ja)
Other versions
JPS58152857A (en
Inventor
Nobuo Ishikawa
Yoshio Inoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikin Industries Ltd
Original Assignee
Daikin Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Kogyo Co Ltd filed Critical Daikin Kogyo Co Ltd
Priority to JP3612582A priority Critical patent/JPS58152857A/en
Publication of JPS58152857A publication Critical patent/JPS58152857A/en
Publication of JPS628431B2 publication Critical patent/JPS628431B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

本発明はフルオロアシル尿玠類又はフルオロア
シルチオ尿玠類に関するものである。 トリフルオロメチル基等のフルオロアルキル基
を有する化合物には、生物掻性を瀺すものが知ら
れおいる。このような含CF3生物掻性物質の合成
䞭間䜓ずしおトリフルオロメチルマロン酞゚ステ
ルは有甚であるず考えられ、このトリフルオロメ
チルマロン酞゚ステル及びその誘導䜓の優れた合
成法を本出願人は特願昭56−155439号においお既
に提案した。この合成法は䟋えば次匏で衚わされ
る。 即ち、オクタフルオロむ゜ブテンずメタノヌ
ルずの反応で生成されるオクタフルオロむ゜ブテ
ン−メタノヌル付加䜓に察し、圓量のトリ゚
チルアミンを反応させ、生じた第四玚゚ノレヌト
アニオンずメタノヌルずの反応で少量のモノ゚
ステルを含むケテンアセタヌルを生成させる。そ
しお、このケテンアセタヌルをメタノヌル䞭で長
時間撹拌すればオルト゚ステルずなるが、そのた
た濃硫酞で凊理しおトリフルオロメチルマロン酞
゚ステルを埗る。たた、このオステルをアルキ
ル化するには、過剰のCsFの存圚䞋でRXハロ
ゲン化アルキルを反応させるず、CF3CR
COOCH32が埗られる。 本発明者は、こうしたトリフルオロメチルマロ
ン酞゚ステル又はそのアルキル化゚ステルを合
成䞭間䜓ずする反応に぀いお皮々怜蚎を加えたず
ころ、぀の問題点に遭遇した。぀たり、䞊蚘゚
ステル又はその誘導䜓は塩基によ぀お容易に分
解するために、尿玠類ずの反応で含CF3バルビツ
ヌル酞の合成に甚いるこずができないこずが刀明
した。これは、次の匏で説明される。 埓぀お、生成物はCF3基を含たないメチルマロ
ン酞゚ステル又はその誘導䜓にしかならない。 本発明は、こうした知芋を考慮しおなされたも
のであ぀お、 䞀般匏 䜆、Rf1及びRf2は同䞀又は異なるパヌフルオ
ロアルキル基、R1及びR2は同䞀又は異なるアル
キル基、は酞玠原子又はむオり原子である。 で衚わされるこずを特城ずする新芏なフルオロア
シル尿玠類又はフルオロアシルチオ尿玠類に係る
ものである。 この新芏なアシル尿玠又はアシルチオ尿玠類は
分子内にパヌフルオロアルキル基を含むゞアルキ
ル尿玠からな぀おいるので、抗りむルス掻性等の
生理掻性を瀺す尿玠系フルオロ化合物の合成䞭間
䜓ずしお有甚であるず考えられる。 このフルオロアシル尿玠又はフルオロアシルチ
オ尿玠の䞊蚘䞀般匏においお、フツ玠源ずしお重
芁なRf1及びRf2は炭玠数以䞋のパヌフルオロア
ルキル基からな぀おいるのがよい。これには、−
CF3、−CF2CF3、−CF2CF2CF3、
The present invention relates to fluoroacylureas or fluoroacylthioureas. Some compounds having a fluoroalkyl group such as a trifluoromethyl group are known to exhibit biological activity. Trifluoromethylmalonic acid ester is considered to be useful as a synthetic intermediate for such CF3- containing biologically active substances, and the applicant has filed a patent application for an excellent synthetic method for trifluoromethylmalonic acid ester and its derivatives. It was already proposed in No. 155439 of 1982. This synthesis method is expressed, for example, by the following formula. That is, the octafluoroisobutene-methanol adduct 2 produced by the reaction of octafluoroisobutene 1 and methanol is reacted with 2 equivalents of triethylamine, and a small amount is reacted with the resulting quaternary enolate anion 3 and methanol. A ketene acetal containing a monoester of is produced. Then, if this ketene acetal is stirred in methanol for a long time, it becomes an orthoester, but it is directly treated with concentrated sulfuric acid to obtain trifluoromethylmalonic acid ester 4. Also, to alkylate this oster, reacting RX (alkyl halide) in the presence of excess CsF results in CF 3 CR
(COOCH 3 ) 2 is obtained. The present inventor conducted various studies on reactions using such trifluoromethylmalonic acid ester 4 or its alkylated ester as a synthetic intermediate, and encountered one problem. In other words, it was found that the above-mentioned ester 4 or a derivative thereof cannot be used for the synthesis of CF 3 -containing barbituric acid by reaction with ureas because it is easily decomposed by a base. This is explained by the following formula: Therefore, the product is only a methylmalonic acid ester or a derivative thereof that does not contain CF 3 groups. The present invention has been made in consideration of these findings, and has the following general formula: (However, Rf 1 and Rf 2 are the same or different perfluoroalkyl groups, R 1 and R 2 are the same or different alkyl groups, and X is an oxygen atom or a sulfur atom.) It relates to fluoroacylureas or fluoroacylthioureas. Since this new acylurea or acylthiourea consists of a dialkylurea containing a perfluoroalkyl group in its molecule, it is considered to be useful as an intermediate for the synthesis of urea-based fluorocompounds that exhibit physiological activities such as antiviral activity. It will be done. In the above general formula of the fluoroacylurea or fluoroacylthiourea, Rf 1 and Rf 2 , which are important as fluorine sources, preferably consist of a perfluoroalkyl group having 5 or less carbon atoms. This includes −
CF 3 , −CF 2 CF 3 , −CF 2 CF 2 CF 3 ,

【匏】 −CF2CF2CF2CF3、[Formula] −CF 2 CF 2 CF 2 CF 3 ,

【匏】等が挙げ られる。たた、R1及びR2も炭玠原子数以䞋で
よく、−CH3、−C2H5、−CH2CH2CH3、
Examples include [Formula]. Further, R 1 and R 2 may also have 5 or less carbon atoms, and may include -CH 3 , -C 2 H 5 , -CH 2 CH 2 CH 3 ,

【匏】−CH2CH2CH2CH3、[Formula] −CH 2 CH 2 CH 2 CH 3 ,

【匏】等が挙げられる。 たた、本発明による䞊蚘フルオロアシル尿玠又
はフルオロアシルチオ尿玠からは、特に塩基䟋
えばトリ゚チルアミン等の第䞉玚アミンの䜜甚
による脱フツ化氎玠䞋の環化反応を経お䞋蚘䞀般
匏で衚わされる閉環化合物が導びかれるのが望た
しい。 䞀般匏 䜆、Rf3はパヌフルオロアルキル基、R1及び
R2は同䞀又は異なる䞊蚘したず同様のアルキル
基、は酞玠原子又はむオり原子、はフツ玠原
子、フルオロアルキル基又はゞアルキルアミノ基
である。 この閉環化合物は、生理掻性物質又はその合成
䞭間䜓ずしお有甚である。䟋えば、この閉環化合
物は、抗りむルス掻性、制がん䜜甚等の薬理䜜甚
のある公知の−トリフルオロメチル−2′−デオ
キシりリゞン又は−トリフルオロメチルチミゞ
ンに導くこずのできる合成䞭間䜓ず類䌌の構造か
らな぀おいるので、これず同様の合成䞭間䜓ずし
お期埅できるものである。 そしお䞊蚘䞀般匏䞭、Rf3は䞊述したRf1又は
Rf2ず同様の炭玠原子数以䞋のパヌフルオロア
ルキル基からな぀おいるのがよい。たた、はフ
ツ玠原子の他、䞊述したRf1又はRf2ず同様の炭玠
原子数以䞋のパヌフルオロアルキル基、或いは
炭玠原子数10以䞋のゞアルキルアミノ基䟋えば
CH32N−、C2H52N−、C3H72N−からな
぀おいおよい。 曎に、本発明による䞊蚘フルオロアシル尿玠類
又はフルオロアシルチオ尿玠類は、次の方法に埓
぀お、 䞀般匏 䜆、Rf1及びRf2は䞊蚘したものず同じであ぀
お、炭玠原子数以䞋のパヌフルオロアルキル基
からなるのがよい。 で衚わされるフルオロアルキルカルボン酞フツ化
物ず、 䞀般匏 䜆、R1及びR2は同䞀又は異なる䞊蚘したず
同様のアルキル基、は酞玠原子又はむオり原子
である。 で衚わされるN′−ゞアルキル尿玠又は
N′−ゞアルキルチオ尿玠ずを脱フツ化氎玠䞋で
反応させるこずによ぀お補造するのが望たしい。 この補造方法では、䞊蚘のフルオロアルキルカ
ルボン酞フツ化物は分解するこずなくN′−
ゞアルキル尿玠又はN′−ゞアルキルチオ尿
玠ず脱フツ化氎玠䞋で充分に反応するので、目的
ずするフルオロアシル尿玠又はフルオロアシルチ
オ尿玠を収率良く埗るこずができる。埗られたこ
れらのアシル尿玠は曎に、塩基新たに添加した
トリ゚チルアミン等の第䞉玚アミン、又は
N′−ゞアルキル尿玠の存圚䞋での環化反応
で、䞊蚘した環状化合物に転化させるこずができ
る。 たた、䞊蚘のフルオロアルキルカルボン酞フツ
化物は、次の方法によ぀お合成するのが望たし
い。これによれば、 䞀般匏 䜆、Rf1及びRf2は前蚘したものず同じ、R4
はアルキル基である。 で衚わされるフルオロアルケン−アルコヌル付加
䜓ず、䞀般匏R5 3N䜆、R5は䟋えばR4ず同様
のアルキル基である。で衚わされる第䞉玚アミ
ンずを反応望たしくはフルオロアルケン−アル
コヌル付加䜓圓量に察し第䞉玚アミンを圓量
反応させるこずによ぀お、 䞀般匏 䜆、Rf1、Rf2、R4及びR5は前蚘したものず
同じである。 で衚わされる第四玚アミノ゚ノラヌトを生成さ
せ、この第四玚アミノ゚ノラヌトに匷酞特に、
也燥匷酞ガスを䜜甚させるこずによ぀おフルオ
ロアルキルカルボン酞フツ化物を埗る。 このフルオロアルキルカルボン酞フツ化物の合
成においおは、フルオロアルケン−アルコヌル付
加䜓の䞀般匏䞭、R4は皮々遞択できるが、メチ
ル基、゚チル基、プロピル基等の䜎玚アルキル基
でよい。この付加䜓ずしおは、既述したオクタフ
ルオロむ゜ブテン−メタノヌル付加䜓が䜿甚可胜
である。 次に、本発明をより具䜓的に説明する。 たず、䞋蚘の反応に埓぀お、䟋えばオクタフル
オロむ゜ブテンずメタノヌルずの反応でオクタ
フルオロむ゜ブテン−メタノヌル付加䜓を生成
させ、曎にこの付加䜓21圓量に圓量のトリ゚チ
ルアミンをゞグリム䞭で䜜甚させお、既述したず
同様の第四玚アミノ゚ノラヌトを生成させ、こ
の゚ノラヌトを氷济䞭で也燥塩化氎玠ガスで凊理
しお−トリフルオロメチル−−トリ
フルオロプロピオン酞フツ化物を合成する。 このように合成したフツ化物は単離するこず
なく、曎に尿玠類ず反応させたが、反応は次の劂
く進行し、尿玠及びメチル尿玠からは倫々察応す
るフルオロアシル尿玠が埗られる。 メチル尿玠からは、その䞀玚アミノ基が求栞攻
撃しお生じる生成物のみが埗られた。 しかしながら、このアシル尿玠は、トリ゚チ
ルアミンを䜜甚させおも、期埅された閉環化合物
含CF3ヘテロ環匏化合物は生成しないこずが
分぀た。 これに察し、本発明による䞋蚘の反応に埓぀
お、䞊蚘フツ化物ずゞアルキル尿玠䟋えば、
N′−ゞアルキル尿玠ずを反応させる
ず、察応するフルオロアシル尿玠収率は䟋え
ば34ず共に、その閉環化合物10収率は䟋え
ば50も生成した。 即ち、䞊蚘N′−ゞメチル尿玠の第二玚ア
ミノ基による求栞反応で脱フツ化氎玠䞋でフルオ
ロアシル尿玠を生成する䞀方、䞊蚘N′−
ゞメチル尿玠自䜓の塩基䜜甚によ぀おアシル尿玠
の䞀郚が䞋蚘のように脱フツ化氎玠䞋で自己瞮
合し、閉環化合物10を生成させるものず考えられ
る。 たた、䞊蚘ず10の混合物にトリ゚チルアミン
等の塩基を添加するこずによ぀お、を10に転化
するこずができるこずが分぀た。 これは、䞊蚘の環化反応が塩基の䜜甚で進行す
るこずを瀺しおいる。 この環状化合物10は19FNMRスペクトル分析で
その構造が確認されたが、曎に次のようにゞ゚チ
ルアミン等の第二玚アミンを添加するず容易に付
加脱離反応しお、ゞ゚チルアミノ誘導䜓11が埗ら
れる。 なお、この付加脱離反応は他の反応物質を甚い
おも同様に進行する。䞊蚘10においおCF3基又は
CH3基の代りに特に炭玠原子数以䞋の他のフル
オロアルキル基又はアルキル基が適甚可胜であ
り、たた䞊蚘第二玚アミンのアルキル基ずしお゚
チル基以倖の炭玠原子数以䞋のものも䜿甚可胜
である。䞊蚘の付加脱離反応は宀枩で進行し、ゞ
メチルホルムアミド等の非プロトン性極性溶媒を
甚いお行なうのがよい。 なお、䞊蚘した䟋では、出発原料ずしお−ト
リフルオロメチル−−トリフルオロプ
ロピオン酞フツ化物を䜿甚したが、そのトリフ
ルオロメチル基を他のフルオロアルキル基ずしお
も同様に反応が進行する。 䟋えば、ペンタフルオロ゚チル基ずした堎合、
次のように反応しお目的の環状化合物を埗るこず
ができる。 この堎合、䞭間生成物ずしおのアシル尿玠にお
いお脱フツ化氎玠が起こる䜍眮によ぀お皮類の
環状化合物䞀方は及び䜍共にCF3基が、他
方は䜍にフツ玠原子、䜍にCF3CF2基が結合
したものずな぀おいる。が埗られる。 次に、N′−ゞメチルチオ尿玠ず䞊蚘フツ
化物ずを反応させた堎合、次匏に瀺すようにフ
ルオロアシルチオ尿玠12は埗られるが、その閉環
化合物は同時に埗られなか぀た。しかし、生成し
たフルオロアシルチオ尿玠12にトリ゚チルアミン
等の塩基を䜜甚させるこずによ぀お閉環化合物13
を埗るこずができる。 なお、この閉環化合物13は、䞊蚘した10ず同様
にゞアルキルアミンの䜜甚で、䞊蚘した11ず同様
の察応したゞアルキルアミノ誘導䜓に転化するこ
ずができる。この堎合も、閉環化合物13のCF3
基、CH3基を䞊蚘した他のフルオロアルキル基、
アルキル基ずするこずができ、䜿甚するアミンも
ゞ゚チルアミン以倖の䞊蚘した他のゞアルキルア
ミンも䜿甚できる。 次に、本発明を実斜䟋に぀いお曎に詳现に説明
するが、以䞋の実斜䟋は本発明の技術的思想に基
いお皮々倉圢が可胜であるこずが理解されよう。 実斜䟋  オクタフルオロむ゜ブテン−メタノヌル付加䜓
CF32CHCF2OMe4.6420mmolずゞ
グリム20c.c.を50c.c.の䞉ツ口フラスコに入れた。ト
リ゚チルアミン4.2542mmolを滎䞋し、
宀枩で〜10時間かきたぜるず、玚アンモニり
ム゚ノレヌトが生成した。ここに也燥塩化氎玠ガ
スを氷冷䞋、玄30分吹きこむず、−ト
リフルオロ−−トリフルオロメチル−プロピオ
ン酞フツ化物が生成し、そのたた、
N′−ゞメチル尿玠5.2960mmolを加え、
宀枩で䞀晩かきたぜた䞀晩撹拌しおも反応が終
了しおいない堎合は、塩化氎玠ガスの過剰によ
り、尿玠ず塩を生成しおしたうためであり、ピリ
ゞンを加えお䞭和しおやればよい。。反応溶液を
氎にあけ、油局を分離した埌、ゞ゚チル゚ヌテル
で回抜出し、抜出液、油局を䞀緒にし、氎で、
ゞグリムが゚ヌテル局から消倱するたで掗浄した
通垞回。硫酞マグネシりムで也燥埌、枛
圧䞋で゚ヌテルを留去するず、油状物質が3.82
埗られた1HNMRより、
粗収率79䞊蚘メタヌル付加䜓から。 生成物の分析デヌタは次の通りであ぀
た。 の1HNMR溶媒CDCl3 Ύ2.944.8Hz3H 3.413H 4.46sep6.2Hz1H 8.73br1H の19FNMR倖郚暙準CF3CO2H Ύ−13.36.2Hz 埗られたずの混合物を塩化メチレ
ン15c.c.に溶解し、トリ゚チルアミン1.42
14mmolトリ゚チルアミンの量は、ず
の混合物䞭のの圓量を加えればよ
いを加え、12時間かきたぜた埌、氎で回掗浄
し、硫酞マグネシりムで也燥した。枛圧䞋で塩化
メチレンを留去埌、油状物質3.56粗収率79
埗られた。これを枛圧蒞留するこずにより、
化合物を粟補した。bp112℃0.3mm
 のNMR のIR 1500cm-1Μ 1685 〃 Μ 1735 〃 Μ 参考䟋 0.6783mmol、ゞメチルホルムア
ミドc.c.を10c.c.䞉ツ口フラスコに入れ、氷冷䞋、
ゞ゚チルアミン0.456.2mmolを滎䞋し
た。宀枩で時間撹拌埌、氎にあけた。粘性の高
い油状物質が埗られたが、ゞ゚チル゚ヌテルを加
えるず、きれいな結晶ずなり、これを濟過し、デ
シケヌタヌの䞭で也燥した。生成物の収量は0.52
収率62であ぀た。再結晶には、四塩化炭
玠を甚いた。生成物のmpは125〜126.5℃であ぀
た。 のNMR のIR 1585cm-1Μ 1655 〃 Μ 1710 〃 Μ のE.A.蚈算倀 15.0915.05、47.4947.31、
5.895.78 実斜䟋  CF32CHCF2OMe4.6420mmol、ゞグ
リム20c.c.を50c.c.の䞉ツ口フラスコに入れ、実斜䟋
ず同様に酞フツ化物を生成した埌、その
たた、N′−ゞメチルチオ尿玠6.25
60mmolを加え、宀枩で䞀晩かきたぜた。実斜
䟋ず同様に凊理した埌、゚ヌテルを留去する
ず、固䜓4.92粗収率87を埗たmp114〜
117.5℃。クロロホルムで再結晶を行ない粟補し
たmp119〜120.5℃。 のNMR のI.R. 1545cm-1
Examples include [Formula]. Furthermore, from the above-mentioned fluoroacylurea or fluoroacylthiourea according to the present invention, a ring-closing compound represented by the following general formula can be obtained through a cyclization reaction under dehydrofluorination under the action of a base (for example, a tertiary amine such as triethylamine). Preferably, the compound is derived. General formula: (However, Rf 3 is a perfluoroalkyl group, R 1 and
R 2 is the same or different alkyl group as described above, X is an oxygen atom or a sulfur atom, and Y is a fluorine atom, a fluoroalkyl group or a dialkylamino group. ) This ring-closed compound is useful as a physiologically active substance or a synthetic intermediate thereof. For example, this ring-closed compound is a synthetic intermediate that can lead to 5-trifluoromethyl-2'-deoxyuridine or 5-trifluoromethylthymidine, which has known pharmacological effects such as antiviral activity and anticancer activity. Since it has a similar structure, it can be expected to be a similar synthetic intermediate. In the above general formula, Rf 3 is the above-mentioned Rf 1 or
It is preferably composed of a perfluoroalkyl group having 5 or less carbon atoms, similar to Rf 2 . In addition to the fluorine atom, Y is a perfluoroalkyl group having 5 or less carbon atoms similar to Rf 1 or Rf 2 described above, or a dialkylamino group having 10 or less carbon atoms (for example, (CH 3 ) 2 N- , (C 2 H 5 ) 2 N−, (C 3 H 7 ) 2 N−). Furthermore, the above fluoroacylureas or fluoroacylthioureas according to the present invention can be prepared according to the following method by the general formula: (However, Rf 1 and Rf 2 are the same as those mentioned above, and preferably consist of a perfluoroalkyl group having 5 or less carbon atoms.) A fluoroalkylcarboxylic acid fluoride represented by the general formula: (However, R 1 and R 2 are the same or different alkyl groups as mentioned above, and X is an oxygen atom or a sulfur atom.)
Preferably, it is produced by reacting N'-dialkylthiourea under dehydrofluorination. In this production method, the above-mentioned fluoroalkylcarboxylic acid fluoride is N,N'-
Since it reacts sufficiently with dialkylurea or N,N'-dialkylthiourea under dehydrofluorination, the desired fluoroacylurea or fluoroacylthiourea can be obtained in good yield. These acylureas obtained are further treated with a base (a newly added tertiary amine such as triethylamine, or a
The above-mentioned cyclic compounds can be converted by a cyclization reaction in the presence of N'-dialkyl urea). Further, the above-mentioned fluoroalkylcarboxylic acid fluoride is preferably synthesized by the following method. According to this, the general formula: (However, Rf 1 and Rf 2 are the same as above, R 4
is an alkyl group. ) is reacted ( preferably By reacting 1 equivalent of fluoroalkene-alcohol adduct with 2 equivalents of tertiary amine, the general formula: (However, Rf 1 , Rf 2 , R 4 and R 5 are the same as above.) The quaternary amino enolate represented by
A fluoroalkylcarboxylic acid fluoride is obtained by reacting with dry strong acid gas). In the synthesis of this fluoroalkylcarboxylic acid fluoride, R 4 in the general formula of the fluoroalkene-alcohol adduct can be selected from various types, and may be a lower alkyl group such as a methyl group, ethyl group, or propyl group. As this adduct, the octafluoroisobutene-methanol adduct described above can be used. Next, the present invention will be explained more specifically. First, according to the following reaction, for example, octafluoroisobutene-methanol adduct 2 is produced by reacting octafluoroisobutene 1 with methanol, and then 2 equivalents of this adduct is reacted with 2 equivalents of triethylamine in diglyme. , the same quaternary amino enolate 3 as previously described is produced, and this enolate is treated with dry hydrogen chloride gas in an ice bath to produce 2-trifluoromethyl-3,3,3-trifluoropropionic acid fluoride. Synthesize 5. The fluoride 5 synthesized in this way was not isolated and was further reacted with ureas. The reaction proceeded as follows, and the corresponding fluoroacylureas 6 were obtained from urea and methylurea. From methylurea, only the product produced by nucleophilic attack of its primary amino group was obtained. However, it was found that this acylurea 7 did not produce the expected ring-closing compound (CF 3 -containing heterocyclic compound) even when treated with triethylamine. In contrast, according to the following reaction according to the present invention, the above fluoride 5 and dialkylurea (e.g.
When reacted with N,N'-dialkyl urea 8), the corresponding fluoroacylurea 9 (yield, e.g. 34%) and its ring-closed compound 10 (yield, e.g. 50%) were also produced. That is, a nucleophilic reaction with the secondary amino group of the N,N'-dimethylurea produces fluoroacylurea 9 under dehydrofluorination, while the N,N'-
It is thought that due to the basic action of dimethylurea itself, a part of acylurea 9 undergoes self-condensation under dehydrofluorination as described below to produce ring-closed compound 10. It was also found that 9 could be converted to 10 by adding a base such as triethylamine to the mixture of 9 and 10. This indicates that the above cyclization reaction proceeds under the action of a base. The structure of this cyclic compound 10 was confirmed by 19 FNMR spectrum analysis, but when a secondary amine such as diethylamine is further added as described below, an addition-elimination reaction easily occurs to obtain diethylamino derivative 11. Note that this addition-elimination reaction proceeds in the same manner even if other reactants are used. In 10 above, 3 CF or
In place of the CH 3 group, other fluoroalkyl groups or alkyl groups having up to 5 carbon atoms can be used, and groups other than ethyl groups with up to 5 carbon atoms can also be used as the alkyl group of the secondary amine. It is possible. The above addition-elimination reaction proceeds at room temperature and is preferably carried out using an aprotic polar solvent such as dimethylformamide. In the above example, 2-trifluoromethyl-3,3,3-trifluoropropionic acid fluoride 5 was used as the starting material, but the reaction can be performed in the same way by using the trifluoromethyl group as another fluoroalkyl group. progresses. For example, when using a pentafluoroethyl group,
The desired cyclic compound can be obtained by reacting as follows. In this case, there are two types of cyclic compounds depending on the position where dehydrofluorination occurs in the acylurea as an intermediate product (one has a CF 3 group at both the 4 and 5 positions, the other has a fluorine atom at the 4 position and a fluorine atom at the 5 position). ) is obtained, in which two CF 3 CF groups are bonded. Next, when N,N'-dimethylthiourea and the above fluoride 5 were reacted, fluoroacylthiourea 12 was obtained as shown in the following formula, but its ring-closed compound was not obtained at the same time. However, by reacting the generated fluoroacylthiourea 12 with a base such as triethylamine, a ring-closing compound 13 can be obtained.
can be obtained. Note that this ring-closing compound 13 can be converted into a corresponding dialkylamino derivative similar to the above-mentioned 11 by the action of a dialkylamine, similarly to the above-mentioned 10. Again, the CF3 of the closed ring compound 13
group, CH 3 group to other fluoroalkyl groups mentioned above,
It can be an alkyl group, and the amine used can also be the above-mentioned dialkylamines other than diethylamine. Next, the present invention will be described in more detail with reference to examples, but it will be understood that various modifications can be made to the following examples based on the technical idea of the present invention. Example 1 Octafluoroisobutene-methanol adduct ((CF 3 ) 2 CHCF 2 OMe): 4.64 g (20 mmol) and diglyme 20 cc. were placed in a 50 cc. three-necked flask. Triethylamine: 4.25g (42mmol) was added dropwise,
Stirring at room temperature for 9-10 hours produced quaternary ammonium enolate. When dry hydrogen chloride gas is blown into this under ice cooling for about 30 minutes, 3,3,3-trifluoro-2-trifluoromethyl-propionic acid fluoride () is produced, and as it is, N,
Add N'-dimethylurea: 5.29g (60mmol),
Stir overnight at room temperature. (If the reaction is not complete even after stirring overnight, this is because the excess hydrogen chloride gas will generate urea and salts. Neutralize by adding pyridine.) ). Pour the reaction solution into water, separate the oil layer, extract three times with diethyl ether, combine the extract and oil layer, and add water.
Washing was performed until the diglyme disappeared from the ether layer (usually 5 or 6 times). After drying with magnesium sulfate, the ether was distilled off under reduced pressure, leaving 3.82 g of an oily substance.
Obtained ( 1HNMR ():()=4:6,
Crude yield 79% (from the above metal adduct). The analytical data of the product () was as follows. 1 HNMR of () (solvent: CDCl 3 ): ή = 2.94 (d, J = 4.8Hz, 3H) 3.41 (s, 3H) 4.46 (sep, J = 6.2Hz, 1H) 8.73 (br, 1H) () 19 FNMR (external standard: CF 3 CO 2 H): ή = −13.3 (d, J = 6.2 Hz) The obtained mixture of () and () was dissolved in 15 c.c. of methylene chloride, and triethylamine: 1.42 g
(14 mmol) (the amount of triethylamine can be determined by adding 2 equivalents of () in the mixture of () and ()), and after stirring for 12 hours, the mixture was washed with water three times and dried over magnesium sulfate. After distilling off methylene chloride under reduced pressure, 3.56 g of oily substance (crude yield 79
%) obtained. By distilling this under reduced pressure,
Compound () was purified. (bp112℃/0.3mmH
g) NMR of (): IR of (): 1500cm -1 (Μc=c) 1685 〃 (Μc=o) 1735 〃 (Μc=o) Reference example (): 0.678 g (3 mmol) and 3 c.c. of dimethylformamide were placed in a 10 c.c. three-necked flask, and cooled on ice.
Diethylamine: 0.45 g (6.2 mmol) was added dropwise. After stirring at room temperature for 1 hour, it was poured into water. A highly viscous oil was obtained which, upon addition of diethyl ether, formed into clean crystals which were filtered and dried in a desiccator. Product yield is 0.52
g (yield 62%). Carbon tetrachloride was used for recrystallization. The mp of the product was 125-126.5°C. NMR of (): IR of (): 1585cm -1 (Μc=c) 1655 〃 (Μc=o) 1710 〃 (Μc=o) EA (calculated value) (%) of (): N: 15.09 (15.05), C: 47.49 ( 47.31), H:
5.89 (5.78) Example 2 (CF 3 ) 2 CHCF 2 OMe: 4.64 g (20 mmol) and diglyme 20 c.c. were placed in a 50 c.c. three-necked flask to produce acid fluoride () in the same manner as in Example 1, and then N, N'-dimethylthiourea 6.25g
(60 mmol) was added and stirred overnight at room temperature. After treatment in the same manner as in Example 1, ether was distilled off to obtain 4.92 g of solid (crude yield: 87%) (mp114~
117.5℃). It was purified by recrystallization with chloroform (mp119-120.5°C). NMR of (): IR of (): 1545cm -1

【匏】 1665 〃 Μ のE.A. 9.689.93、29.2129.79、
2.752.86。
[Formula] 1665 〃 (Μc=o) () EA: N: 9.68 (9.93), C: 29.21 (29.79), H:
2.75 (2.86).

Claims (1)

【特蚱請求の範囲】  䞀般匏 䜆、Rf1及びRf2は同䞀又は異なるパヌフルオ
ロアルキル基、R1及びR2は同䞀又は異なるアル
キル基、は酞玠原子又はむオり原子である。 で衚されるこずを特城ずするフルオロアシル尿玠
類又はフルオロアシルチオ尿玠類。  Rf1及びRf2の炭玠原子数が以䞋である、特
蚱請求の範囲の第項に蚘茉した尿玠類。  R1及びR2の炭玠原子数が以䞋である、特
蚱請求の範囲の第項又は第項に蚘茉した尿玠
類。
[Claims] 1. General formula: (However, Rf 1 and Rf 2 are the same or different perfluoroalkyl groups, R 1 and R 2 are the same or different alkyl groups, and X is an oxygen atom or a sulfur atom.) Acyl ureas or fluoroacyl thioureas. 2. The ureas described in claim 1, wherein the number of carbon atoms in Rf 1 and Rf 2 is 5 or less. 3. The ureas described in claim 1 or 2 , wherein the number of carbon atoms in R 1 and R 2 is 5 or less.
JP3612582A 1982-03-08 1982-03-08 Fluoroacylureas or fluoroacylthioureas Granted JPS58152857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3612582A JPS58152857A (en) 1982-03-08 1982-03-08 Fluoroacylureas or fluoroacylthioureas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3612582A JPS58152857A (en) 1982-03-08 1982-03-08 Fluoroacylureas or fluoroacylthioureas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP61107419A Division JPS61257977A (en) 1986-05-09 1986-05-09 Fluorine-containing heterocyclic compound

Publications (2)

Publication Number Publication Date
JPS58152857A JPS58152857A (en) 1983-09-10
JPS628431B2 true JPS628431B2 (en) 1987-02-23

Family

ID=12461055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3612582A Granted JPS58152857A (en) 1982-03-08 1982-03-08 Fluoroacylureas or fluoroacylthioureas

Country Status (1)

Country Link
JP (1) JPS58152857A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7884202B2 (en) 2005-11-09 2011-02-08 Tosoh Corporation Nucleobase having perfluoroalkyl group and process for producing the same
JP5053622B2 (en) * 2005-11-09 2012-10-17 東゜ヌ株匏䌚瀟 Nucleobase having a perfluoroalkyl group and method for producing the same

Also Published As

Publication number Publication date
JPS58152857A (en) 1983-09-10

Similar Documents

Publication Publication Date Title
EP1254883B1 (en) Process for producing substituted 1,1,1-trifluoro-3-butene-2-ones
JPH04230260A (en) Process for producing 2-chloro-5-methylpyridine
JP3186886B2 (en) Method for producing 2-chloro-5-methyl-pyridine
EP3807268B1 (en) Process for the preparation of lifitegrast
JP2007538041A (en) Method for producing diphenylazetidinone derivative
JP3180192B2 (en) Dithiocarbamic acid salts, method for producing the same, and method for producing isothiocyanates using the dithiocarbamic acid salts
JPS628431B2 (en)
DE69605541T2 (en) INTERMEDIATES FOR THE SYNTHESIS OF ARTHROPODICIDAL OXADIAZINE
CN110511197B (en) A kind of N-furanonyl arylsulfonyl hydrazone compound and its synthesis method and application
KR870002019B1 (en) Process for preparation of amine derivatives
JPS61257977A (en) Fluorine-containing heterocyclic compound
DE69213264T2 (en) Process for the preparation of fluorobenzene derivatives and related compounds
JP7607304B2 (en) Triazinedione Compounds
KR100244881B1 (en) Method for the preparation of 2-chloro-5-methyl-pyridines
JPH11503446A (en) Novel carbamate compound containing N-substituted thiocarbamoyl group and method for producing the same
KR820000786B1 (en) Process for preparing uracil derivatives
US4234514A (en) Method of preparing ketoxime carbamates
JP4123606B2 (en) Process for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine
RU2159239C2 (en) Method of preparing 3-(alpha-methoxy)methylenebenzofurans
KR960005519B1 (en) Novel ethylidene dithio carbazic acid derivatives and the preparation thereof
JP3107405B2 (en) Bis (2-chloro-4-fluoro-5-nitrophenyl) carbonate and method for producing the same
JPH0316339B2 (en)
JPS58144381A (en) β-ketoester derivative and method for producing the same
JPH09316056A (en) Process for producing cyclic nitroguanidine derivative
JPH11322663A (en) Production of gamma-fluoroacetoacetic acid derivative